ACT Genomics and mProbe Announce Strategic Partnership to Advance Precision Medicine in Asia
ACT Genomics Co. Limited, aleader in precision diagnostics and clinical testing, and mProbe Taiwan Inc., apioneer in proteomics technology for precision health, have signed a Memorandumof Understanding (MOU) to collaborate on advancing precision medicine acrossAsia. The agreement aims to combine the unique expertise of both companies toprovide cutting-edge diagnostic solutions to healthcare providers in theregion.
(1).jpg)
